Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Jefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of DUSA PHARMACEUTICALS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.

28 Dec 2012 Jefferson Research 11 $127.00

Wright Investors Service Comprehensive Report for Dusa Pharmaceuticals, Inc.

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

25 Dec 2012 Wright Reports 41 $472.00

C. K. COOPER-DUSA PHARMACEUTICALS-EXCELLENT PHASE II RESULTS

Summary: Profoundly Positive BASDI Phase II Data. We clearly see this data as providing compelling clinical evidence that the...

17 Dec 2012 C.K. Cooper & Company 6 $46.00

Value Graph: DUSA PHARMACEUT -- DUSA

14 Dec 2012 Ford Investor Services, Inc. 1 $12.00

DUSA PHARM INC (DUSA) Zacks Company Snapshot

11 Dec 2012 Zacks Investment Research Inc. 1 $12.00

DUSA Pharmaceuticals, Inc (DUSA) - Financial and Strategic SWOT Analysis Review

DUSA Pharmaceuticals, Inc (DUSA) - Financial and Strategic SWOT Analysis Review Summary DUSA Pharmaceuticals, Inc. (DUSA) is ...

05 Dec 2012 GlobalData 36 $125.00

DUSA PHARM INC (DUSA) Zacks Company Snapshot

26 Nov 2012 Zacks Investment Research Inc. 1 $12.00

DUSA PHARM INC (DUSA) Zacks Company Snapshot

23 Nov 2012 Zacks Investment Research Inc. 1 $12.00

DUSA: New Due Diligence Review: Forensic Earnings and Valuation

Reports provide superior value and incorporate critical data from the Financial Footnotes and MD&A that other firms miss. The...

09 Nov 2012 New Constructs, LLC 13 $25.00

C. K. COOPER-DUSA PHARMACEUTICALS INC-KEY TERMS TO SUN OFFER

Summary: Having read the merger agreement, DUSA shareholders should be encouraged to learn that the Board, while accepting th...

09 Nov 2012 C.K. Cooper & Company 8 $69.00